• Contact

  • Newsletter

  • About us

  • Delivery options

  • Prospero Book Market Podcast

  • News

  • Therapeutic Treatment for Benign Prostatic Hyperplasia

    Therapeutic Treatment for Benign Prostatic Hyperplasia by Kirby, Roger S.; McConnell, John D.; Fitzpatrick, John;

      • GET 20% OFF

      • The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
      • Publisher's listprice GBP 175.00
      • The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

        88 567 Ft (84 350 Ft + 5% VAT)
      • Discount 20% (cc. 17 713 Ft off)
      • Discounted price 70 854 Ft (67 480 Ft + 5% VAT)

    88 567 Ft

    db

    Availability

    Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
    Not in stock at Prospero.

    Why don't you give exact delivery time?

    Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.

    Product details:

    • Edition number 1
    • Publisher CRC Press
    • Date of Publication 16 June 2005

    • ISBN 9781841846019
    • Binding Hardback
    • No. of pages210 pages
    • Size 246x189 mm
    • Weight 771 g
    • Language English
    • 0

    Categories

    Short description:

    This highly illustrated guide covers a range of both medical and phytotherapeutic treatment options for BPH, and presents physicians with all they require to successfully manage the disease.

    More

    Long description:

    The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90% of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease.


    Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists, such as terazosin, doxazosin, alfuzosin and tamsulosin, and the 5-alpha-reductase inhibitors, finasteride and dutasteride. Other strategies, such as plant-derived medication or watchful waiting, are applied to varying extents.


    Derived from the benchmark title on BPH - Textbook of Benign Prostatic Hyperplasia - this well written and highly illustrated guide covers all these therapies and presents physicians with all they need to know to successfully manage the disease.

    More

    Table of Contents:

    1. Medical Management - Watchful Waiting  2. The Placebo Effect in the Treatment of Benign Prostatic Hyperplasia  3. Dutasteride in the Treatment of the BPH Patient  4. Finasteride in the Treatment of Benign Prostatic Hyperplasia  5. Combination Therapy in the Treatment of BPH  6. The Differential Effects of Adrenoceptor Antagonists on Prostate Tissue Growth  7. Terazosin in the Treatment of the Lower Urinary Tract  8. Doxazosin in the Treatment of Benign Prostatic Hyperplasia  9. Alfuzosin  10. Tamsulosin  11. Phytotherapeutic Agents in the Treatment of LUTS and BPH  12. Uroselectivity Revisited

    More